title: Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I.
abstract: NKX3.1 (NK3 homeobox 1) is a prostate tumour suppressor protein with a number of activities that are critical for its role in tumour suppression. NKX3.1 mediates the cellular response to DNA damage by interacting with ATM (ataxia telangiectasia mutated) and by activation of topoisomerase I. In the present study we characterized the interaction between NKX3.1 and topoisomerase I. The NKX3.1 homeodomain binds to a region of topoisomerase I spanning the junction between the core and linker domains. Loss of the topoisomerase I N-terminal domain, a region for frequent protein interactions, did not affect binding to NKX3.1 as was shown by the activation of Topo70 (N-terminal truncated topoisomerase I) in vitro. In contrast, NKX3.1 interacts with the enzyme reconstituted from peptide fragments of the core and linker active site domains, but inhibits the DNA-resolving activity of the reconstituted enzyme in vitro. The effect of NKX3.1 on both Topo70 and the reconstituted enzyme was seen in the presence and absence of camptothecin. Neither NKX3.1 nor CPT (camptothecin) had an effect on the interaction of the other with topoisomerase I. Therefore the interactions of NKX3.1 and CPT with the linker domain of topoisomerase I are mutually exclusive. However, in cells the effect of NKX3.1 on topoisomerase binding to DNA sensitized the cells to cellular toxicity and the induction of apoptosis by low doses of CPT. Lastly, topoisomerase I is important for the effect of NKX3.1 on cell survival after DNA damage as topoisomerase knockdown blocked the effect of NKX3.1 on clonogenicity after DNA damage. Therefore NKX3.1 and topoisomerase I interact in vitro and in cells to affect the CPT sensitivity and DNA-repair functions of NKX3.1.
authors.affiliation: Departments of Medicine and Pathology, Herbert Irving Comprehensive Cancer Center, Columbia University, 177 Ft. Washington Avenue, MHB 6N-435, New York, NY 10032, USA.
authors.forename: Liang-Nian
authors.initials: LN
authors.lastname: Song
authors.forename: Cai
authors.initials: C
authors.lastname: Bowen
authors.forename: Edward P
authors.initials: EP
authors.lastname: Gelmann
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D002166:Camptothecin / Q000494:pharmacology; D045744:Cell Line, Tumor; D004249:DNA Damage / Q000187:drug effects; D004260:DNA Repair / Q000187:drug effects; D004264:DNA Topoisomerases, Type I / Q000378:metabolism*; D018398:Homeodomain Proteins / Q000378:metabolism*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism*; D025521:Tumor Suppressor Proteins / Q000378:metabolism
chemical_list: D018398:Homeodomain Proteins; C491178:NKX3-1 protein, human; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; D004264:DNA Topoisomerases, Type I; C528909:TOP1 protein, human; D002166:Camptothecin
references.citation: J Biol Chem. 1998 Aug 7;273(32):20390-6
references.pmid: 9685392
references.citation: J Mol Biol. 1997 Jun 13;269(3):355-72
references.pmid: 9199405
references.citation: Mech Dev. 1998 Jan;70(1-2):25-34
references.pmid: 9510022
references.citation: Cancer Res. 2005 Feb 15;65(4):1164-73
references.pmid: 15734999
references.citation: Genes Dev. 1999 Apr 15;13(8):966-77
references.pmid: 10215624
references.citation: Science. 1998 Mar 6;279(5356):1504-13
references.pmid: 9488644
references.citation: DNA Repair (Amst). 2003 Oct 7;2(10):1115-26
references.pmid: 13679149
references.citation: Anal Biochem. 1993 Apr;210(1):179-87
references.pmid: 8489015
references.citation: Cancer Res. 2006 Jan 1;66(1):69-77
references.pmid: 16397218
references.citation: Cancer Res. 1998 Mar 1;58(5):976-84
references.pmid: 9500459
references.citation: J Biol Chem. 2000 Dec 15;275(50):39061-72
references.pmid: 10993896
references.citation: Cancer Res. 2000 Nov 1;60(21):6111-5
references.pmid: 11085535
references.citation: Nucleic Acids Res. 2000 Jun 15;28(12):2389-95
references.pmid: 10871372
references.citation: Biochemistry (Mosc). 2009 Nov;74(11):1278-84
references.pmid: 19916945
references.citation: Nucleic Acids Res. 2008 Oct;36(17):5645-51
references.pmid: 18765473
references.citation: Cancer Res. 2007 Sep 15;67(18):8752-61
references.pmid: 17875716
references.citation: Oncogene. 2001 Feb 15;20(7):836-48
references.pmid: 11314011
references.citation: Proc Natl Acad Sci U S A. 1987 Aug;84(16):5565-9
references.pmid: 3039492
references.citation: Nature. 2005 Mar 31;434(7033):671-4
references.pmid: 15800630
references.citation: Cell. 1986 Feb 14;44(3):401-7
references.pmid: 3002635
references.citation: Chem Rev. 2009 Jul;109(7):2894-902
references.pmid: 19476377
references.citation: J Biol Chem. 1998 May 1;273(18):10994-1000
references.pmid: 9556579
references.citation: Biochemistry. 2002 Feb 5;41(5):1428-35
references.pmid: 11814334
references.citation: Nat Rev Mol Cell Biol. 2002 Jun;3(6):430-40
references.pmid: 12042765
references.citation: Mol Pharmacol. 1995 May;47(5):907-14
references.pmid: 7538195
references.citation: J Biol Chem. 2003 Oct 31;278(44):43268-75
references.pmid: 12904303
references.citation: J Biol Chem. 2002 Aug 23;277(34):30815-23
references.pmid: 12077150
references.citation: Biochim Biophys Acta. 1998 Oct 1;1400(1-3):223-32
references.pmid: 9748592
references.citation: Cancer Res. 2002 May 1;62(9):2654-9
references.pmid: 11980664
references.citation: Annu Rev Biochem. 2001;70:369-413
references.pmid: 11395412
references.citation: Cancer Res. 2002 Jun 1;62(11):2999-3004
references.pmid: 12036903
references.citation: Cancer Res. 2010 Apr 15;70(8):3089-97
references.pmid: 20395202
references.citation: Cancer Res. 2000 Aug 15;60(16):4538-43
references.pmid: 10969804
references.citation: Cancer Res. 1989 Feb 1;49(3):605-12
references.pmid: 2535961
references.citation: J Mol Biol. 2006 Jul 28;360(5):989-99
references.pmid: 16814806
references.citation: J Virol. 2000 Jun;74(11):5224-32
references.pmid: 10799598
references.citation: Cancer Res. 2006 Nov 15;66(22):10683-90
references.pmid: 17108105
references.citation: Cancer Res. 2007 Jan 15;67(2):455-64
references.pmid: 17234752
references.citation: J Biol Chem. 1996 Dec 13;271(50):31779-82
references.pmid: 8943214
references.citation: Biochim Biophys Acta. 1998 Oct 1;1400(1-3):83-105
references.pmid: 9748515